<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">UNITED STATES</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">WASHINGTON, D.C.&#160;&#160;20549</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">FORM 8-K</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">CURRENT REPORT PURSUANT TO
SECTION 13 OR 15 (D) OF</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">SECURITIES EXCHANGE ACT OF
1934</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">Date of report (Date of earliest
event reported)</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">January 30, 2012</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<HR ALIGN="CENTER" STYLE="width: 25%; color: Black">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">INNOVUS PHARMACEUTICALS, INC.</P>

<HR STYLE="width: 40%; color: Black">

<P STYLE="margin: 0pt"></P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">(Exact name of registrant
as specified in its charter)</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">NEVADA</P>

<HR STYLE="width: 45%; color: Black">

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction
of Incorporation)<BR>
</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</P>

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; border-bottom: black 2px solid; text-align: center">000-52991</TD>
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 45%; border-bottom: black 2px solid; text-align: center">87-0324697</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0pt">(Commission File Number</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(IRS Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 2px solid; width: 64%; text-align: center; text-indent: 0pt">80 West Sierra Madre Blvd., #392, Sierra Madre,</TD>
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 2px solid; width: 27%; text-align: center; text-indent: 0pt">CA 91024</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0pt">(Address of Principal Executive Offices)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0pt">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">626-241-2094</P>
<HR STYLE="width: 45%; color: Black">

<P  STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">(Registrant&#8217;s Telephone
Number, Including Area Code)</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">North Horizon, Inc.</P>

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">2290 East 4500 South, Suite
130, Salt Lake City, Utah 84117<BR>
</P>

<HR STYLE="width: 45%; color: Black">

<P STYLE="text-align: center; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">(Former name and Former Address,
if changed Since Last Report)</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: left; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif">Check the appropriate box if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36pt; text-align: center"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="text-align: left">Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</TD></TR>
</TABLE>
<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36pt; text-align: center"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="text-align: left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR240.14a-12)</TD></TR>
</TABLE>
<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36pt; text-align: center"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="text-align: left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR>
</TABLE>
<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE ALIGN="CENTER" BORDER="0" CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 36pt; text-align: center"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT></TD>
    <TD STYLE="text-align: left">Pre-commencement communications pursuant to Rule 133-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))</TD></TR>
</TABLE>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: left; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On January 30, 2012, Innovus Pharmaceuticals,
Inc. dismissed the accounting firm of Pritchett Siler and Hardy, P.C., (&quot;Pritchett&quot;) as the Company's independent registered
public accounting firm. The dismissal of Pritchett was approved by the Audit Committee of the Board of Directors of the Company.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pritchett's prior reports for the years
ended December 31, 2010 and 2009 had no adverse opinion or disclaimer of opinion and were not modified or qualified as to uncertainty,
audit scope or accounting principle, except that their report for the years ended December 31, 2010, and December 31, 2009, contained
explanatory language regarding substantial doubt about the Company's ability to continue as a going concern.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">For the years ended December 31, 2010,
and 2009, and through the date of this current report on Form 8-K (the &quot;Report&quot;), there have been no disagreements with
Pritchett on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which
disagreement if not resolved to the satisfaction of Pritchett would have caused them to make reference thereto in their reports
on the financial statements for such years or during any interim periods through the date of this Report, and there were no reportable
events within the meaning set forth in Item 301(a)(1)(v) of Regulation S-K.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">A copy of the disclosures contained within
this Report are being provided to Pritchett, and the Company requested that Pritchett furnish it with a letter addressed to the
Securities and Exchange Commission (the &quot;Commission&quot;) stating whether or not it agrees with the above statements so that
it can be filed with the Commission within ten (10) business days after the filing of this Report.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Engagement of Independent Registered public Accounting Firm</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On January 30, 2012, the Company engaged
EisnerAmper LLP (&quot;Eisner&quot;) as the Registrant&rsquo;s new independent registered public account firm and the Company's
independent auditing firm for the year ended December 31, 2011. The decision to engage Eisner was approved by the Board of Directors
of the Company. Prior to Eisner's engagement the Company did not consult with Eisner and receive either written or oral advice
from Eisner and that was an important factor considered by the Company in its decision as to application of accounting principles
to a specific completed or contemplated transaction, or the type of audit opinion that might be rendered on the Company's financial
statements. In addition, the Company has not consulted with Eisner concerning any matter that was the subject of a disagreement
or a reportable event, each as described in Item 304 (a)(1)(iv) and Item 304 (a)(1)(v) of Regulation S-K.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">ITEM 7.01 FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION
AND EXHIBITS.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">a)</TD>
    <TD STYLE="width: 94%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Not Applicable.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">b)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Not Applicable.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">c)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Exhibits</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><U>No</U>.&nbsp;&nbsp; <U>Exhibits</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">16.1&nbsp; Letter from Pritchett, Siler and Hardy, P.C., dated February 1, 2012, to the Securities and Exchange Commission regarding statements included in this Form 8-K.</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt">&nbsp;</DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Date:</TD>
    <TD STYLE="width: 89%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">February 1, 2012.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">By:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><U>/s/ Vivian Liu</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Name:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Vivian Liu</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">President</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">EXHIBIT INDEX</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><U>Exhibit No.</U></TD>
    <TD STYLE="width: 86%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><U>Description of Exhibit</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">16.1</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">Letter from Pritchett, Siler and Hardy, P.C., dated February 1, 2012, to the Securities and Exchange Commission regarding information included in this Form 8-K</TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="text-align: left; text-indent: 0pt; margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v300965_8k.htm", "description": "8-K CURRENT REPORT", "secsgml_size_bytes": 17345}]
{"company-data": {"conformed-name": "INNOVUS PHARMACEUTICALS, INC.", "cik": "0001411879", "assigned-sic": "6770", "irs-number": "870324697", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52991", "film-number": "12565173"}, "business-address": {"street1": "80 WEST SIERRA MADRE BLVD., #392", "city": "SIERRA MADRE", "state": "CA", "zip": "91024", "phone": "626-355-6730"}, "mail-address": {"street1": "80 WEST SIERRA MADRE BLVD., #392", "city": "SIERRA MADRE", "state": "CA", "zip": "91024"}, "former-company": {"former-conformed-name": "North Horizon, Inc.", "date-changed": "20070910"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15 (D) OF
SECURITIES EXCHANGE ACT OF
1934
Date of report (Date of earliest
event reported)
January 30, 2012
INNOVUS PHARMACEUTICALS, INC.
(Exact name of registrant
as specified in its charter)
NEVADA
(State or Other Jurisdiction
of Incorporation)
000-52991
87-0324697
(Commission File Number
(IRS Employer Identification No.)
80 West Sierra Madre Blvd., #392, Sierra Madre,
CA 91024
(Address of Principal Executive Offices)
(Zip Code)
626-241-2094
(Registrant's Telephone
Number, Including Area Code)
North Horizon, Inc.
2290 East 4500 South, Suite
130, Salt Lake City, Utah 84117
(Former name and Former Address,
if changed Since Last Report)
Check the appropriate box if
the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
£
Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR240.14a-12)
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£
Pre-commencement communications pursuant to Rule 133-4(c) under the Exchange Act (17 CFR 240. 13e-4(c))
ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
On January 30, 2012, Innovus Pharmaceuticals,
Inc. dismissed the accounting firm of Pritchett Siler and Hardy, P.C., ("Pritchett") as the Company's independent registered
public accounting firm. The dismissal of Pritchett was approved by the Audit Committee of the Board of Directors of the Company.
Pritchett's prior reports for the years
ended December 31, 2010 and 2009 had no adverse opinion or disclaimer of opinion and were not modified or qualified as to uncertainty,
audit scope or accounting principle, except that their report for the years ended December 31, 2010, and December 31, 2009, contained
explanatory language regarding substantial doubt about the Company's ability to continue as a going concern.
For the years ended December 31, 2010,
and 2009, and through the date of this current report on Form 8-K (the "Report"), there have been no disagreements with
Pritchett on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which
disagreement if not resolved to the satisfaction of Pritchett would have caused them to make reference thereto in their reports
on the financial statements for such years or during any interim periods through the date of this Report, and there were no reportable
events within the meaning set forth in Item 301(a)(1)(v) of Regulation S-K.
A copy of the disclosures contained within
this Report are being provided to Pritchett, and the Company requested that Pritchett furnish it with a letter addressed to the
Securities and Exchange Commission (the "Commission") stating whether or not it agrees with the above statements so that
it can be filed with the Commission within ten (10) business days after the filing of this Report.
Engagement of Independent Registered public Accounting Firm
On January 30, 2012, the Company engaged
EisnerAmper LLP ("Eisner") as the Registrant's new independent registered public account firm and the Company's
independent auditing firm for the year ended December 31, 2011. The decision to engage Eisner was approved by the Board of Directors
of the Company. Prior to Eisner's engagement the Company did not consult with Eisner and receive either written or oral advice
from Eisner and that was an important factor considered by the Company in its decision as to application of accounting principles
to a specific completed or contemplated transaction, or the type of audit opinion that might be rendered on the Company's financial
statements. In addition, the Company has not consulted with Eisner concerning any matter that was the subject of a disagreement
or a reportable event, each as described in Item 304 (a)(1)(iv) and Item 304 (a)(1)(v) of Regulation S-K.
ITEM 7.01 FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION
AND EXHIBITS.
a)
Not Applicable.
b)
Not Applicable.
c)
Exhibits
No
.
Exhibits
16.1  Letter from Pritchett, Siler and Hardy, P.C., dated February 1, 2012, to the Securities and Exchange Commission regarding statements included in this Form 8-K.
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date:
February 1, 2012.
By:
/s/ Vivian Liu
Name:
Vivian Liu
Title:
President
EXHIBIT INDEX
Exhibit No.
Description of Exhibit
16.1
Letter from Pritchett, Siler and Hardy, P.C., dated February 1, 2012, to the Securities and Exchange Commission regarding information included in this Form 8-K